Lemaitre Vascular (LMAT) Tops Q4 EPS by 10c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- US and Iran discuss phased deal to reopen Hormuz and end US blockade, sources say
LeMaitre Vascular Announces Q4 2018 Financial Results
February 19, 2019 4:05 PM ESTBURLINGTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services, today reported Q4 2018 results, provided guidance, announced a 21% dividend increase to $0.085/share and announced a share repurchase program.
Q4 2018 Results
Record sales of $28.4mm, +9% (+6% organic) vs. Q4 2017Operating income of $7.2mm vs. $6.3mm, +14%Net income of $6.0mm vs. $4.3mm, +41%Earnings of $0.30 per diluted share vs. $0.21, +41%EBITDA of $8.3mm vs. $7.4mm, +13%    ÂQ4 2018 sales were driven by embolectomy catheters,... More
